人iPS细胞酶试剂盒Takara


人iPS细胞
品牌 Code No. 产品名称 包装量 价格(元) 说明书 数量
Cellartis Y00275 Cellartis® human iPS cell line 7 (ChiPSC7) Kit 1 Kit ¥22,525 人iPS细胞 人iPS细胞 人iPS细胞
Cellartis Y00285 Cellartis® human iPS cell line 12 (ChiPSC12) Kit 1 kit ¥22,525 人iPS细胞 人iPS细胞 人iPS细胞
Cellartis Y00315 Cellartis® human iPS cell line 21 (ChiPSC21) Kit 1 Kit ¥22,525 人iPS细胞 人iPS细胞 人iPS细胞
Cellartis Y00325 Cellartis® human iPS cell line 22 (ChiPSC22) Kit 1 kit ¥22,525 人iPS细胞 人iPS细胞 人iPS细胞
Cellartis Y00305 Cellartis® human iPS cell line 18 (ChiPSC18) Kit 1 Kit ¥22,525 人iPS细胞 人iPS细胞 人iPS细胞
收藏产品 加入购物车

无标题文档

人iPS细胞
(Human Induced Pluripotent Stem Cells)
Cellartis人iPS细胞(Human iPS Cell Line)产品是达到了工业客户使用标准生产的干细胞产品。该产品包括细胞和用于增殖培养的Cellartis DEF-CS Culture System培养体系。iPS细胞已经在制品化时完成了对DEF-CS培养体系的适应。Cellartis DEF-CS Culture System培养体系是组分明确而且不依赖饲养层的便捷的干细胞培养体系。Cellartis DEF-CS Culture System适合高效率地增殖培养干细胞,并且保持干细胞在增殖过程中几乎无分化地生长,这使得不需要在大规模增殖培养过程中进行细胞筛选。因此,Cellartis人iPS细胞(Human iPS Cell Line)产品是一套完整的产品体系,对于科研级别和工业规模的需求都适合。
 
■ 产品特点
· Cell lines were created by reprogramming human skin fibroblasts using defective polycistronic retrovirus technology to deliver Oct-4, SOX2, KLF4, and c-Myc
· Cell lines are extensively analyzed for purity and stem-cell characteristics, including recovery after thawing, absence of mycoplasma and bacteria, expression of stem cell-specific markers (Oct-4, NANOG, SSEA-3, SSEA-4, TRA-1-60, TRA-1-81), absence of differentiation markers (Beta-3 tubulin, FOXA2, ASMA), and expected karyotype
· Optimized for culture with the Cellartis DEF-CS Culture System
· Suitable for all major applications; cells can form derivatives of all three germ layers when differentiated
· Kits include the Cellartis DEF-CS 100 Culture System
 
■ 关联产品
Code No. Product Size
Y30010 Cellartis® DEF-CS 500 Culture System 1 Kit
 
■ 产品详情请点击:人iPS细胞
 
人iPS细胞
Characteristics of Cellartis human iPS cells. The cell lines were generated from fibroblasts using defective polycistronic retrovirus technology to deliver Oct-4, Sox-2, KLF-4, and c-Myc. The skin fibroblasts were obtained from donors of varying age and gender, have a normal karyotype, and have been confirmed to differentiate into specific cell lineages. Consent was obtained from all donors for commercial use.
 
参考文献:
1. de Peppo GM, et al. Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng Part A.2010 Nov;16(11):3413-3426.
2. Both SK, et al. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med.2011 Mar;5(3):180-190.
3. de Peppo GM, et al. Free-form-fabricated commercially pure Ti and Ti6A14V Porous Scaffolds support the growth of human embryonic stem cell-derived mesodermal progenitors. ScientificWorldJournal. 2012;2012:646417.Epub 2012 Jan 4.
4. Ou Li, et al. Human embryonic stem cell-derived mesenchymal stroma cells(hES-MSCs) engraft in vivo and support hematopoiesis without suppression immune function: implications for off –the shelf ES-MSC therapies. PLOS ONE.2013; 8(1):e55319.
 

发表回复